nodes	percent_of_prediction	percent_of_DWPC	metapath
Plerixafor—Induration—Pamidronate—Paget's disease of bone	0.0267	0.0267	CcSEcCtD
Plerixafor—Induration—Zoledronate—Paget's disease of bone	0.0244	0.0244	CcSEcCtD
Plerixafor—Musculoskeletal pain—Alendronate—Paget's disease of bone	0.0158	0.0158	CcSEcCtD
Plerixafor—Arthralgia—Tiludronate—Paget's disease of bone	0.0143	0.0143	CcSEcCtD
Plerixafor—Inflammation—Risedronate—Paget's disease of bone	0.0129	0.013	CcSEcCtD
Plerixafor—Musculoskeletal pain—Risedronate—Paget's disease of bone	0.0127	0.0127	CcSEcCtD
Plerixafor—Musculoskeletal discomfort—Tiludronate—Paget's disease of bone	0.0125	0.0125	CcSEcCtD
Plerixafor—Inflammation—Pamidronate—Paget's disease of bone	0.0123	0.0123	CcSEcCtD
Plerixafor—Musculoskeletal pain—Pamidronate—Paget's disease of bone	0.0121	0.0121	CcSEcCtD
Plerixafor—Dyspepsia—Tiludronate—Paget's disease of bone	0.012	0.012	CcSEcCtD
Plerixafor—Pain—Tiludronate—Paget's disease of bone	0.0117	0.0117	CcSEcCtD
Plerixafor—Inflammation—Zoledronate—Paget's disease of bone	0.0112	0.0112	CcSEcCtD
Plerixafor—Gastrointestinal pain—Tiludronate—Paget's disease of bone	0.0112	0.0112	CcSEcCtD
Plerixafor—Musculoskeletal pain—Zoledronate—Paget's disease of bone	0.011	0.011	CcSEcCtD
Plerixafor—Injection site reaction—Zoledronate—Paget's disease of bone	0.0108	0.0108	CcSEcCtD
Plerixafor—Abdominal pain—Tiludronate—Paget's disease of bone	0.0108	0.0108	CcSEcCtD
Plerixafor—Abdominal distension—Alendronate—Paget's disease of bone	0.00988	0.00989	CcSEcCtD
Plerixafor—Swelling—Pamidronate—Paget's disease of bone	0.00981	0.00983	CcSEcCtD
Plerixafor—Asthenia—Tiludronate—Paget's disease of bone	0.00981	0.00982	CcSEcCtD
Plerixafor—Abdominal discomfort—Alendronate—Paget's disease of bone	0.00941	0.00942	CcSEcCtD
Plerixafor—Diarrhoea—Tiludronate—Paget's disease of bone	0.00935	0.00937	CcSEcCtD
Plerixafor—Dizziness—Tiludronate—Paget's disease of bone	0.00904	0.00905	CcSEcCtD
Plerixafor—Swelling—Zoledronate—Paget's disease of bone	0.00896	0.00898	CcSEcCtD
Plerixafor—Headache—Tiludronate—Paget's disease of bone	0.00856	0.00857	CcSEcCtD
Plerixafor—Nausea—Tiludronate—Paget's disease of bone	0.00812	0.00813	CcSEcCtD
Plerixafor—Erythema—Etidronic acid—Paget's disease of bone	0.00802	0.00803	CcSEcCtD
Plerixafor—Abdominal distension—Risedronate—Paget's disease of bone	0.00792	0.00793	CcSEcCtD
Plerixafor—Flatulence—Etidronic acid—Paget's disease of bone	0.00791	0.00791	CcSEcCtD
Plerixafor—Haemoglobin—Alendronate—Paget's disease of bone	0.00789	0.0079	CcSEcCtD
Plerixafor—Haemorrhage—Alendronate—Paget's disease of bone	0.00785	0.00786	CcSEcCtD
Plerixafor—Abdominal discomfort—Risedronate—Paget's disease of bone	0.00755	0.00756	CcSEcCtD
Plerixafor—Abdominal distension—Zoledronate—Paget's disease of bone	0.00688	0.00689	CcSEcCtD
Plerixafor—Erythema—Alendronate—Paget's disease of bone	0.00684	0.00684	CcSEcCtD
Plerixafor—Arthralgia—Etidronic acid—Paget's disease of bone	0.00683	0.00684	CcSEcCtD
Plerixafor—Discomfort—Etidronic acid—Paget's disease of bone	0.00675	0.00676	CcSEcCtD
Plerixafor—Flatulence—Alendronate—Paget's disease of bone	0.00674	0.00674	CcSEcCtD
Plerixafor—Abdominal discomfort—Zoledronate—Paget's disease of bone	0.00655	0.00656	CcSEcCtD
Plerixafor—Ill-defined disorder—Alendronate—Paget's disease of bone	0.00634	0.00635	CcSEcCtD
Plerixafor—Haemoglobin—Risedronate—Paget's disease of bone	0.00633	0.00634	CcSEcCtD
Plerixafor—Haemorrhage—Risedronate—Paget's disease of bone	0.0063	0.00631	CcSEcCtD
Plerixafor—Connective tissue disorder—Risedronate—Paget's disease of bone	0.00619	0.0062	CcSEcCtD
Plerixafor—Malaise—Alendronate—Paget's disease of bone	0.00616	0.00617	CcSEcCtD
Plerixafor—Haemoglobin—Pamidronate—Paget's disease of bone	0.00602	0.00603	CcSEcCtD
Plerixafor—Haemorrhage—Pamidronate—Paget's disease of bone	0.00599	0.006	CcSEcCtD
Plerixafor—Musculoskeletal discomfort—Etidronic acid—Paget's disease of bone	0.00597	0.00597	CcSEcCtD
Plerixafor—Connective tissue disorder—Pamidronate—Paget's disease of bone	0.00589	0.00589	CcSEcCtD
Plerixafor—Paraesthesia—Etidronic acid—Paget's disease of bone	0.00588	0.00589	CcSEcCtD
Plerixafor—Dyspepsia—Etidronic acid—Paget's disease of bone	0.00576	0.00577	CcSEcCtD
Plerixafor—Discomfort—Alendronate—Paget's disease of bone	0.00575	0.00576	CcSEcCtD
Plerixafor—Immune system disorder—Risedronate—Paget's disease of bone	0.00569	0.0057	CcSEcCtD
Plerixafor—Constipation—Etidronic acid—Paget's disease of bone	0.0056	0.00561	CcSEcCtD
Plerixafor—Mental disorder—Risedronate—Paget's disease of bone	0.00552	0.00553	CcSEcCtD
Plerixafor—Immune system disorder—Pamidronate—Paget's disease of bone	0.00541	0.00542	CcSEcCtD
Plerixafor—Flatulence—Risedronate—Paget's disease of bone	0.0054	0.00541	CcSEcCtD
Plerixafor—Feeling abnormal—Etidronic acid—Paget's disease of bone	0.0054	0.0054	CcSEcCtD
Plerixafor—Connective tissue disorder—Zoledronate—Paget's disease of bone	0.00538	0.00538	CcSEcCtD
Plerixafor—Gastrointestinal pain—Etidronic acid—Paget's disease of bone	0.00535	0.00536	CcSEcCtD
Plerixafor—Erythema—Pamidronate—Paget's disease of bone	0.00521	0.00522	CcSEcCtD
Plerixafor—Urticaria—Etidronic acid—Paget's disease of bone	0.0052	0.00521	CcSEcCtD
Plerixafor—Abdominal pain—Etidronic acid—Paget's disease of bone	0.00518	0.00518	CcSEcCtD
Plerixafor—Musculoskeletal discomfort—Alendronate—Paget's disease of bone	0.00508	0.00509	CcSEcCtD
Plerixafor—Immune system disorder—Zoledronate—Paget's disease of bone	0.00494	0.00495	CcSEcCtD
Plerixafor—Syncope—Risedronate—Paget's disease of bone	0.00492	0.00492	CcSEcCtD
Plerixafor—Dyspepsia—Alendronate—Paget's disease of bone	0.00491	0.00492	CcSEcCtD
Plerixafor—Ill-defined disorder—Pamidronate—Paget's disease of bone	0.00484	0.00484	CcSEcCtD
Plerixafor—Hypersensitivity—Etidronic acid—Paget's disease of bone	0.00482	0.00483	CcSEcCtD
Plerixafor—Loss of consciousness—Risedronate—Paget's disease of bone	0.00482	0.00483	CcSEcCtD
Plerixafor—Mental disorder—Zoledronate—Paget's disease of bone	0.00479	0.0048	CcSEcCtD
Plerixafor—Pain—Alendronate—Paget's disease of bone	0.00477	0.00478	CcSEcCtD
Plerixafor—Constipation—Alendronate—Paget's disease of bone	0.00477	0.00478	CcSEcCtD
Plerixafor—Erythema—Zoledronate—Paget's disease of bone	0.00476	0.00477	CcSEcCtD
Plerixafor—Malaise—Pamidronate—Paget's disease of bone	0.0047	0.00471	CcSEcCtD
Plerixafor—Syncope—Pamidronate—Paget's disease of bone	0.00468	0.00468	CcSEcCtD
Plerixafor—Arthralgia—Risedronate—Paget's disease of bone	0.00467	0.00468	CcSEcCtD
Plerixafor—Unspecified disorder of skin and subcutaneous tissue—Risedronate—Paget's disease of bone	0.00464	0.00464	CcSEcCtD
Plerixafor—Pruritus—Etidronic acid—Paget's disease of bone	0.00463	0.00464	CcSEcCtD
Plerixafor—Feeling abnormal—Alendronate—Paget's disease of bone	0.0046	0.0046	CcSEcCtD
Plerixafor—Loss of consciousness—Pamidronate—Paget's disease of bone	0.00458	0.00459	CcSEcCtD
Plerixafor—Dry mouth—Risedronate—Paget's disease of bone	0.00457	0.00457	CcSEcCtD
Plerixafor—Gastrointestinal pain—Alendronate—Paget's disease of bone	0.00456	0.00457	CcSEcCtD
Plerixafor—Diarrhoea—Etidronic acid—Paget's disease of bone	0.00448	0.00449	CcSEcCtD
Plerixafor—Arthralgia—Pamidronate—Paget's disease of bone	0.00444	0.00444	CcSEcCtD
Plerixafor—Urticaria—Alendronate—Paget's disease of bone	0.00443	0.00444	CcSEcCtD
Plerixafor—Ill-defined disorder—Zoledronate—Paget's disease of bone	0.00442	0.00442	CcSEcCtD
Plerixafor—Abdominal pain—Alendronate—Paget's disease of bone	0.00441	0.00442	CcSEcCtD
Plerixafor—Shock—Risedronate—Paget's disease of bone	0.0044	0.00441	CcSEcCtD
Plerixafor—Nervous system disorder—Risedronate—Paget's disease of bone	0.00439	0.0044	CcSEcCtD
Plerixafor—Discomfort—Pamidronate—Paget's disease of bone	0.00439	0.00439	CcSEcCtD
Plerixafor—Skin disorder—Risedronate—Paget's disease of bone	0.00435	0.00435	CcSEcCtD
Plerixafor—Malaise—Zoledronate—Paget's disease of bone	0.0043	0.0043	CcSEcCtD
Plerixafor—Syncope—Zoledronate—Paget's disease of bone	0.00427	0.00428	CcSEcCtD
Plerixafor—Anaphylactic shock—Pamidronate—Paget's disease of bone	0.00426	0.00426	CcSEcCtD
Plerixafor—Shock—Pamidronate—Paget's disease of bone	0.00419	0.00419	CcSEcCtD
Plerixafor—Loss of consciousness—Zoledronate—Paget's disease of bone	0.00419	0.00419	CcSEcCtD
Plerixafor—Nervous system disorder—Pamidronate—Paget's disease of bone	0.00417	0.00418	CcSEcCtD
Plerixafor—Vomiting—Etidronic acid—Paget's disease of bone	0.00416	0.00417	CcSEcCtD
Plerixafor—Rash—Etidronic acid—Paget's disease of bone	0.00413	0.00413	CcSEcCtD
Plerixafor—Dermatitis—Etidronic acid—Paget's disease of bone	0.00412	0.00413	CcSEcCtD
Plerixafor—Hyperhidrosis—Pamidronate—Paget's disease of bone	0.00411	0.00412	CcSEcCtD
Plerixafor—Hypersensitivity—Alendronate—Paget's disease of bone	0.00411	0.00412	CcSEcCtD
Plerixafor—Headache—Etidronic acid—Paget's disease of bone	0.0041	0.00411	CcSEcCtD
Plerixafor—Musculoskeletal discomfort—Risedronate—Paget's disease of bone	0.00408	0.00408	CcSEcCtD
Plerixafor—Arthralgia—Zoledronate—Paget's disease of bone	0.00405	0.00406	CcSEcCtD
Plerixafor—Insomnia—Risedronate—Paget's disease of bone	0.00405	0.00405	CcSEcCtD
Plerixafor—Unspecified disorder of skin and subcutaneous tissue—Zoledronate—Paget's disease of bone	0.00403	0.00403	CcSEcCtD
Plerixafor—Paraesthesia—Risedronate—Paget's disease of bone	0.00402	0.00402	CcSEcCtD
Plerixafor—Discomfort—Zoledronate—Paget's disease of bone	0.00401	0.00401	CcSEcCtD
Plerixafor—Asthenia—Alendronate—Paget's disease of bone	0.004	0.00401	CcSEcCtD
Plerixafor—Dyspnoea—Risedronate—Paget's disease of bone	0.00399	0.004	CcSEcCtD
Plerixafor—Dry mouth—Zoledronate—Paget's disease of bone	0.00397	0.00397	CcSEcCtD
Plerixafor—Pruritus—Alendronate—Paget's disease of bone	0.00395	0.00395	CcSEcCtD
Plerixafor—Dyspepsia—Risedronate—Paget's disease of bone	0.00394	0.00395	CcSEcCtD
Plerixafor—Nausea—Etidronic acid—Paget's disease of bone	0.00389	0.00389	CcSEcCtD
Plerixafor—Anaphylactic shock—Zoledronate—Paget's disease of bone	0.00389	0.00389	CcSEcCtD
Plerixafor—Musculoskeletal discomfort—Pamidronate—Paget's disease of bone	0.00388	0.00388	CcSEcCtD
Plerixafor—Gastrointestinal disorder—Risedronate—Paget's disease of bone	0.00386	0.00387	CcSEcCtD
Plerixafor—Fatigue—Risedronate—Paget's disease of bone	0.00386	0.00386	CcSEcCtD
Plerixafor—Insomnia—Pamidronate—Paget's disease of bone	0.00385	0.00385	CcSEcCtD
Plerixafor—Pain—Risedronate—Paget's disease of bone	0.00383	0.00383	CcSEcCtD
Plerixafor—Constipation—Risedronate—Paget's disease of bone	0.00383	0.00383	CcSEcCtD
Plerixafor—Shock—Zoledronate—Paget's disease of bone	0.00382	0.00383	CcSEcCtD
Plerixafor—Paraesthesia—Pamidronate—Paget's disease of bone	0.00382	0.00383	CcSEcCtD
Plerixafor—Diarrhoea—Alendronate—Paget's disease of bone	0.00382	0.00382	CcSEcCtD
Plerixafor—Nervous system disorder—Zoledronate—Paget's disease of bone	0.00381	0.00382	CcSEcCtD
Plerixafor—Dyspnoea—Pamidronate—Paget's disease of bone	0.00379	0.0038	CcSEcCtD
Plerixafor—Skin disorder—Zoledronate—Paget's disease of bone	0.00378	0.00378	CcSEcCtD
Plerixafor—Hyperhidrosis—Zoledronate—Paget's disease of bone	0.00376	0.00376	CcSEcCtD
Plerixafor—Dyspepsia—Pamidronate—Paget's disease of bone	0.00375	0.00375	CcSEcCtD
Plerixafor—Dizziness—Alendronate—Paget's disease of bone	0.00369	0.00369	CcSEcCtD
Plerixafor—Gastrointestinal disorder—Pamidronate—Paget's disease of bone	0.00367	0.00368	CcSEcCtD
Plerixafor—Fatigue—Pamidronate—Paget's disease of bone	0.00367	0.00367	CcSEcCtD
Plerixafor—Gastrointestinal pain—Risedronate—Paget's disease of bone	0.00366	0.00366	CcSEcCtD
Plerixafor—Pain—Pamidronate—Paget's disease of bone	0.00364	0.00364	CcSEcCtD
Plerixafor—Constipation—Pamidronate—Paget's disease of bone	0.00364	0.00364	CcSEcCtD
Plerixafor—Urticaria—Risedronate—Paget's disease of bone	0.00356	0.00356	CcSEcCtD
Plerixafor—Vomiting—Alendronate—Paget's disease of bone	0.00355	0.00355	CcSEcCtD
Plerixafor—Musculoskeletal discomfort—Zoledronate—Paget's disease of bone	0.00354	0.00355	CcSEcCtD
Plerixafor—Abdominal pain—Risedronate—Paget's disease of bone	0.00354	0.00354	CcSEcCtD
Plerixafor—Rash—Alendronate—Paget's disease of bone	0.00352	0.00352	CcSEcCtD
Plerixafor—Insomnia—Zoledronate—Paget's disease of bone	0.00352	0.00352	CcSEcCtD
Plerixafor—Dermatitis—Alendronate—Paget's disease of bone	0.00351	0.00352	CcSEcCtD
Plerixafor—Feeling abnormal—Pamidronate—Paget's disease of bone	0.00351	0.00351	CcSEcCtD
Plerixafor—Headache—Alendronate—Paget's disease of bone	0.0035	0.0035	CcSEcCtD
Plerixafor—Paraesthesia—Zoledronate—Paget's disease of bone	0.00349	0.00349	CcSEcCtD
Plerixafor—Gastrointestinal pain—Pamidronate—Paget's disease of bone	0.00348	0.00348	CcSEcCtD
Plerixafor—Dyspnoea—Zoledronate—Paget's disease of bone	0.00347	0.00347	CcSEcCtD
Plerixafor—Dyspepsia—Zoledronate—Paget's disease of bone	0.00342	0.00343	CcSEcCtD
Plerixafor—Abdominal pain—Pamidronate—Paget's disease of bone	0.00336	0.00337	CcSEcCtD
Plerixafor—Gastrointestinal disorder—Zoledronate—Paget's disease of bone	0.00336	0.00336	CcSEcCtD
Plerixafor—Fatigue—Zoledronate—Paget's disease of bone	0.00335	0.00336	CcSEcCtD
Plerixafor—Pain—Zoledronate—Paget's disease of bone	0.00332	0.00333	CcSEcCtD
Plerixafor—Constipation—Zoledronate—Paget's disease of bone	0.00332	0.00333	CcSEcCtD
Plerixafor—Nausea—Alendronate—Paget's disease of bone	0.00331	0.00332	CcSEcCtD
Plerixafor—Hypersensitivity—Risedronate—Paget's disease of bone	0.0033	0.0033	CcSEcCtD
Plerixafor—Asthenia—Risedronate—Paget's disease of bone	0.00321	0.00322	CcSEcCtD
Plerixafor—Feeling abnormal—Zoledronate—Paget's disease of bone	0.0032	0.00321	CcSEcCtD
Plerixafor—Gastrointestinal pain—Zoledronate—Paget's disease of bone	0.00318	0.00318	CcSEcCtD
Plerixafor—Pruritus—Risedronate—Paget's disease of bone	0.00317	0.00317	CcSEcCtD
Plerixafor—Hypersensitivity—Pamidronate—Paget's disease of bone	0.00314	0.00314	CcSEcCtD
Plerixafor—Urticaria—Zoledronate—Paget's disease of bone	0.00309	0.00309	CcSEcCtD
Plerixafor—Abdominal pain—Zoledronate—Paget's disease of bone	0.00307	0.00308	CcSEcCtD
Plerixafor—Diarrhoea—Risedronate—Paget's disease of bone	0.00306	0.00307	CcSEcCtD
Plerixafor—Asthenia—Pamidronate—Paget's disease of bone	0.00305	0.00306	CcSEcCtD
Plerixafor—Pruritus—Pamidronate—Paget's disease of bone	0.00301	0.00301	CcSEcCtD
Plerixafor—Dizziness—Risedronate—Paget's disease of bone	0.00296	0.00296	CcSEcCtD
Plerixafor—Diarrhoea—Pamidronate—Paget's disease of bone	0.00291	0.00292	CcSEcCtD
Plerixafor—Hypersensitivity—Zoledronate—Paget's disease of bone	0.00286	0.00287	CcSEcCtD
Plerixafor—Vomiting—Risedronate—Paget's disease of bone	0.00285	0.00285	CcSEcCtD
Plerixafor—Rash—Risedronate—Paget's disease of bone	0.00282	0.00283	CcSEcCtD
Plerixafor—Dermatitis—Risedronate—Paget's disease of bone	0.00282	0.00282	CcSEcCtD
Plerixafor—Dizziness—Pamidronate—Paget's disease of bone	0.00281	0.00282	CcSEcCtD
Plerixafor—Headache—Risedronate—Paget's disease of bone	0.0028	0.00281	CcSEcCtD
Plerixafor—Asthenia—Zoledronate—Paget's disease of bone	0.00279	0.00279	CcSEcCtD
Plerixafor—Pruritus—Zoledronate—Paget's disease of bone	0.00275	0.00275	CcSEcCtD
Plerixafor—Vomiting—Pamidronate—Paget's disease of bone	0.00271	0.00271	CcSEcCtD
Plerixafor—Rash—Pamidronate—Paget's disease of bone	0.00268	0.00269	CcSEcCtD
Plerixafor—Dermatitis—Pamidronate—Paget's disease of bone	0.00268	0.00268	CcSEcCtD
Plerixafor—Headache—Pamidronate—Paget's disease of bone	0.00267	0.00267	CcSEcCtD
Plerixafor—Diarrhoea—Zoledronate—Paget's disease of bone	0.00266	0.00266	CcSEcCtD
Plerixafor—Nausea—Risedronate—Paget's disease of bone	0.00266	0.00266	CcSEcCtD
Plerixafor—Dizziness—Zoledronate—Paget's disease of bone	0.00257	0.00257	CcSEcCtD
Plerixafor—Nausea—Pamidronate—Paget's disease of bone	0.00253	0.00253	CcSEcCtD
Plerixafor—Vomiting—Zoledronate—Paget's disease of bone	0.00247	0.00247	CcSEcCtD
Plerixafor—Rash—Zoledronate—Paget's disease of bone	0.00245	0.00245	CcSEcCtD
Plerixafor—Dermatitis—Zoledronate—Paget's disease of bone	0.00245	0.00245	CcSEcCtD
Plerixafor—Headache—Zoledronate—Paget's disease of bone	0.00244	0.00244	CcSEcCtD
Plerixafor—Nausea—Zoledronate—Paget's disease of bone	0.00231	0.00231	CcSEcCtD
Plerixafor—CXCR4—Hematopoietic Stem Cell Differentiation—CSF1—Paget's disease of bone	0.000473	0.405	CbGpPWpGaD
Plerixafor—CXCR4—CXCR4-mediated signaling events—INPP5D—Paget's disease of bone	0.000198	0.17	CbGpPWpGaD
Plerixafor—CXCR4—HIV Life Cycle—NUP205—Paget's disease of bone	0.000158	0.135	CbGpPWpGaD
Plerixafor—CXCR4—HIV Infection—NUP205—Paget's disease of bone	0.000109	0.0934	CbGpPWpGaD
Plerixafor—CXCR4—GPCR ligand binding—CALCA—Paget's disease of bone	4.59e-05	0.0393	CbGpPWpGaD
Plerixafor—CXCR4—Disease—VCP—Paget's disease of bone	3.5e-05	0.03	CbGpPWpGaD
Plerixafor—CXCR4—Disease—NUP205—Paget's disease of bone	2.68e-05	0.0229	CbGpPWpGaD
Plerixafor—CXCR4—GPCR downstream signaling—CALCA—Paget's disease of bone	2.59e-05	0.0222	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—VCP—Paget's disease of bone	2.45e-05	0.021	CbGpPWpGaD
Plerixafor—CXCR4—Signaling by GPCR—CALCA—Paget's disease of bone	2.35e-05	0.0201	CbGpPWpGaD
Plerixafor—CXCR4—Disease—CALCA—Paget's disease of bone	1.99e-05	0.017	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—SQSTM1—Paget's disease of bone	1.43e-05	0.0123	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—CALCA—Paget's disease of bone	1.39e-05	0.0119	CbGpPWpGaD
